U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
7014170141The Use of a Computer Program to Help Primary Care Providers Treat Patients With Type 2 DiabetesActive, not recruitingNo Results AvailableType II Diabetes MellitusOther: Computer-Assisted Decision Supporthttps://ClinicalTrials.gov/show/NCT01648244
7014270142Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health VolunteersCompletedNo Results AvailableHypertensionDrug: Reference Treatment: 1 x 5mg amlodipine tablet and 1 x 100mg losartan tablet administered in fasted state|Drug: Fixed Dose Combination 1: 1 x 5mg amlodipine / 100mg losartan tablet administered in fasted state|Drug: Fixed Dose Combination 2: 1 x 5mg amlodipine / 100mg losartan tablet administered in fasted statehttps://ClinicalTrials.gov/show/NCT01648231
7014370143Insulin Therapy for Post-transplant Glucocorticoid Induced HyperglycemiaRecruitingNo Results AvailablePost-Transplant Glucocorticoid Induced DiabetesDrug: Neutral protamine hagedorn (NPH) insulin|Drug: Regular human insulin or Insulin Aspart|Drug: Insulin glarginehttps://ClinicalTrials.gov/show/NCT01648218
7014470144Efficacy Study of Sodium Channel Blocker in LQT3 PatientsRecruitingNo Results AvailableLong QT SyndromeDrug: Placebo|Drug: Ranolazinehttps://ClinicalTrials.gov/show/NCT01648205
7014570145Phase I Study of GW856553 (Losmapimod)CompletedNo Results AvailableAcute Coronary SyndromeDrug: Losmapimod for single dose|Drug: Losmapimod for repeat dosehttps://ClinicalTrials.gov/show/NCT01648192
7014670146A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy SubjectsCompletedNo Results AvailableInfections, BacterialDrug: GSK1322322 (mesylate salt) Powder for Injection|Drug: GSK1322322 (freebase) tablets|Drug: GSK1322322 (mesylate salt) Powder for Oral Solution|Drug: GSK1322322 (freebase) tablets FEDhttps://ClinicalTrials.gov/show/NCT01648179
7014770147A Population-based Case-control Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental CarcinogensActive, not recruitingNo Results AvailableLung Cancerhttps://ClinicalTrials.gov/show/NCT01648166
7014870148Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DMCompletedNo Results AvailableDiabetes MellitusBiological: GSK1070806|Other: Placebo (saline)|Biological: GSK1070806https://ClinicalTrials.gov/show/NCT01648153
7014970149Dose Ranging of GSK2336805 in Combination TherapyCompletedNo Results AvailableHepatitis C, ChronicDrug: GSK2336805 40 mg|Drug: GSK2336805 60 mg|Drug: Pegylated interferon alpha-2a|Drug: Ribavirin|Drug: Telaprevirhttps://ClinicalTrials.gov/show/NCT01648140
7015070150Pharmacokinetics of Ceftaroline in Normal and Obese SubjectsCompletedNo Results AvailableDrug SafetyDrug: Ceftarolinehttps://ClinicalTrials.gov/show/NCT01648127
7015170151A Randomized Controlled Trial of an Antenatal Intervention to Increase Exclusive BreastfeedingCompletedNo Results AvailableBreastfeeding|PregnancyOther: Antenatal Breastfeeding Interventionhttps://ClinicalTrials.gov/show/NCT01648114
7015270152Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset SeizuresTerminatedHas ResultsEpilepsyDrug: Retigabine 900mg/day|Drug: Retigabine 600mg/day|Other: Placebohttps://ClinicalTrials.gov/show/NCT01648101
7015370153Detection of Staph Colonization in Pre-op Arthroplasty PatientsCompletedNo Results AvailableSurgical Site Infectionhttps://ClinicalTrials.gov/show/NCT01648088
7015470154Effect of the Consumption of Probiotics in the Reduction of Incidence of Carious Lesions in Preschool ChildrenCompletedNo Results AvailableCaries Reduction|Caries PreventionDietary Supplement: Experimental: Probiotic enriched milkhttps://ClinicalTrials.gov/show/NCT01648075
7015570155Sleep Self-Regulation Using Mental ImageryCompletedNo Results AvailableSleep Deprivation|InsomniaBehavioral: Sleep Self-Regulation Using Mental Imageryhttps://ClinicalTrials.gov/show/NCT01648062
7015670156Treatment of Insomnia and Depression in Elders (TIDE)Active, not recruitingNo Results AvailableDepression|InsomniaBehavioral: Integrated Cognitive Behavioral Therapy (CBT)|Behavioral: Treatment as usualhttps://ClinicalTrials.gov/show/NCT01648049
7015770157Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO PilotCompletedNo Results AvailableSeptic ShockDrug: Unfractionated heparin|Drug: Dalteparinhttps://ClinicalTrials.gov/show/NCT01648036
7015870158Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and CisplatinRecruitingNo Results AvailableUnresectable Intrahepatic CholangiocarcinomaDevice: LC Bead with Gem-Cis|Drug: Gemcitabine and Cisplatinhttps://ClinicalTrials.gov/show/NCT01648023
7015970159Safety and Tolerability Study Which Evaluate Intravesical Instillation With Mitomycin C Mixed With TC-3 Drug Retaining Hydrogel Device In Patients With Muscle Invasive Bladder CancerCompletedNo Results AvailableCarcinoma of Urinary Bladder, InvasiveDevice: TC-3 gel|Device: TC-3 gel mixed with Mitomycin C (MMC)https://ClinicalTrials.gov/show/NCT01648010
7016070160Lactate Metabolism After an Endotoxin Challenge in Healthy HumansCompletedNo Results AvailableSepsisOther: bacterial endotoxin challengehttps://ClinicalTrials.gov/show/NCT01647997
7016170161Role of a Combination of Nutraceuticals (Ritmonutra) on Benign Supraventricular and Ventricular ArrhythmiasRecruitingNo Results AvailableVentricular and Atrial ExtrasytolesDietary Supplement: Ritmonutra|Dietary Supplement: placebohttps://ClinicalTrials.gov/show/NCT01647984
7016270162Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomaActive, not recruitingNo Results AvailableNon-Hodgkins Lymphoma|B-cell Lymphoma|Waldenstrom's Macroglobulinemia|Marginal Zone Lymphoma|Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma|Primary Central Nervous System LymphomaDrug: Ublituximabhttps://ClinicalTrials.gov/show/NCT01647971
7016370163The EndoGastric Solutions TEMPO TrialActive, not recruitingNo Results AvailableGastroesophageal Reflux Disease (GERD)Device: EsophyX System with SerosaFuse fastenershttps://ClinicalTrials.gov/show/NCT01647958
7016470164FK506 (Tacrolimus) in Pulmonary Arterial HypertensionTerminatedNo Results AvailablePulmonary Arterial HypertensionDrug: Placebo|Drug: FK506 level - https://ClinicalTrials.gov/show/NCT01647945
7016570165Safety and Efficacy of the Combination of Loop With Thiazide-type Diuretics in Patients With Decompensated Heart FailureRecruitingNo Results AvailableHeart FailureDrug: hydrochlorothiazide|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01647932
7016670166Effects of cogniVidaâ„¢ on Learning and Memory and in Comparison to Placebo After Long-term SupplementationCompletedNo Results AvailableHealthyDietary Supplement: cogniVidaâ„¢ 100 mg/day|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01647919
7016770167Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)Enrolling by invitationNo Results AvailableFecal Incontinencehttps://ClinicalTrials.gov/show/NCT01647906
7016870168Phase 1 Single Dose Escalation Study of CTB-001RecruitingNo Results AvailableHealthyDrug: CTB-001https://ClinicalTrials.gov/show/NCT01647893
7016970169MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study)RecruitingNo Results AvailableMultiple SclerosisDrug: Verum arm receiving Gilenya®|Drug: Active Comparator receiving Extavia®https://ClinicalTrials.gov/show/NCT01647880
7017070170Expression of Met Receptor Fragments in Non Small Cell Lung CancerRecruitingNo Results AvailableNon Small Cell Lung CancerOther: Met analysis on tissue and bloodhttps://ClinicalTrials.gov/show/NCT01647867

* Görseller ve İçerik tekif hakkına sahip olabilir